[The 1989 Bichat Conference. A new therapeutic orientation in arterial hypertension: the action of rilmenidine (Hyperium 1 mg) on the so-called imidazoline receptors].
Fillastre
J P
JP
Service de néphrologie et hémodialyse, hôpital de Boisguillaume.
Dhib
M
M
D000959:Antihypertensive Agents / Q000494:pharmacology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D054755:Imidazoline Receptors; D010080:Oxazoles / Q000494:pharmacology*; D011955:Receptors, Drug / Q000187:drug effects*; D000077769:Rilmenidine
D000959:Antihypertensive Agents; D054755:Imidazoline Receptors; D010080:Oxazoles; D011955:Receptors, Drug; D000077769:Rilmenidine
Entretiens de Bichat 1989. Une nouvelle orientation thérapeutique de l'hypertension artérielle: l'action de la rilmenidine (Hyperium 1 mg) sur les récepteurs dits aux imidazolines.